These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2854901

  • 1. [Leishmaniasis caused by Leishmania viannia braziliensis (Lvb). A case of atypical course].
    Costa JM, Vale KC, França F, Lago EL, Magalhães AV, Marsden PD, Sampaio RN.
    Rev Soc Bras Med Trop; 1988; 21(2):71-3. PubMed ID: 2854901
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.
    Netto EM, Marsden PD, Llanos-Cuentas EA, Costa JM, Cuba CC, Barreto AC, Badaró R, Johnson WD, Jones TC.
    Trans R Soc Trop Med Hyg; 1990; 84(3):367-70. PubMed ID: 2260171
    [Abstract] [Full Text] [Related]

  • 6. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI, Baptista C, Rubin EF, Vasconcellos Ede C, Lyra MR, Salgueiro Mde M, Saheki MN, Rosalino CM, Madeira Mde F, Silva AF, Confort EM, Schubach Ade O.
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation.
    Berhe N, Ali A, Hailu A, Yeneneh H.
    Acta Trop; 1994 Jun; 57(1):83-90. PubMed ID: 7942358
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
    Motta AC, Arruda D, Souza CS, Foss NT.
    Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682
    [Abstract] [Full Text] [Related]

  • 11. Recent advances in the treatment of visceral leishmaniasis.
    Davidson RN, Croft SL.
    Trans R Soc Trop Med Hyg; 1993 Sep; 87(2):130-1, 141. PubMed ID: 8393221
    [No Abstract] [Full Text] [Related]

  • 12. The chemotherapy of protozoal infections: whither?
    Steck EA.
    J Protozool; 1981 Feb; 28(1):30-5. PubMed ID: 6265632
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Leishmaniasis.
    Evans TG.
    Infect Dis Clin North Am; 1993 Sep; 7(3):527-46. PubMed ID: 8254158
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Retention of antimony in hair during leishmaniasis treatment.
    Dorea JG, Merchan-Hamann E, Ryan DE, Holzbecher J.
    Clin Chim Acta; 1989 Feb 22; 179(3):341-5. PubMed ID: 2714007
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.